Jenna Butner, MD, FASAM, AAHIVS
Titles
- Assistant Professor Adjunct of Medicine (General Medicine), Assistant Clinical Professor (Yale School of Nursing)
Education & Training
- MPHYale School of Public Health, Public Health (2024)
- FellowYale University School of Medicine (2015)
- FellowMount Sinai Beth Israel (2014)
- ResidencyAlbert Einstein: Bronx Lebanon (2013)
- MDRoss University School of Medicine, Medicine (2009)
- ABState University of New York , Biology & Spanish (2005)
Languages Spoken
- English
- Español (Spanish)
Additional Information
Honors & Recognitions
- Annenberg Physician Training Program Fellowship Recipient: Ulrich & Ruth Frank Foundation for International Health (2022)
- Employee of the Year: APT Foundation (2015)
- Educational Finalist: American Society of Addiction Medicine: Connecticut Chapter (2015)
- Ruth Fox Scholarship Recipient: American Society of Addiction Medicine (2015)
Board Certifications
- AB of Preventive Medicine, Addiction Medicine (Internal Medicine) (2018)
Professional Service
- Violence Intervention Training, Advocacy and Education (VITAE), Yale School of Public Health (2023 - Present): Co-Founder
- Addiction Science & Clinical Practice (2021 - Present): Reviewer
- International Society of Addiction Medicine, Practice and Policy Interest Group (2020 - Present): Co-Chair
- American Academy of HIV Medicine (2020 - Present): Mentor
- ISAM-NExT (New Professionals Exploration,Training & Education), Mentorship Subcommittee (2020 - Present): Co-Chair
- Journal of Addiction Medicine (2020 - Present): Reviewer
- International Journal of Drug Policy (2020 - Present): Reviewer
- AZAHAR Foundation (2019 - Present): Board Member
- Providers Clinical Support System (PCSS) (2017 - Present): Mentor
- American Academy of HIV Medicine (2016 - Present): Member
Publications
- Dunham K, Hill K, Kazal H, Butner J, Hull I, Sue K, Li L, Doneski K, Dinges B, Rife-Pennington T, Kung S, Thakarar K. In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction). Substance Use & Addiction Journal 2024, 29767342241252590. PMID: 38747578, DOI: 10.1177/29767342241252590.
- Kanabar M, Kathiresan P, Elkholy H, Zonoozi A, Orsolini L, Long J, Farokhnia M, Bhad R, Butner J, Fonseca F, Phan V, Achab S, Potenza M. Spirituality and behavioural addictions: narrative review. BJPsych International 2024, 1-3. DOI: 10.1192/bji.2024.9.
- Allcroft H, Heiman E, Butner J. Clinical progress note: Xylazine use and its sequelae. Journal Of Hospital Medicine 2024 PMID: 38561251, DOI: 10.1002/jhm.13338.
- Ekhtiari H, Khojasteh Zonoozi A, Rafei P, Abolghasemi F, Pemstein D, Abdelgawad T, Achab S, Ghafri H, Al'Absi M, Bisch M, Conti A, Ambekar A, Arunogiri S, Bhad R, Bilici R, Brady K, Bunt G, Busse A, Butner J, Danesh A, El-Khoury J, Omari F, Jokūbonis D, de Jong C, Dom G, Ebrahimi M, Fathi Jouzdani A, Ferri M, Galea-Singer S, Parker D, Higuchi S, Kathiresan P, Khelifa E, Kouimtsidis C, Krupitsky E, Long J, Maremmani I, McGovern G, Mohaddes Ardabili H, Rahimi-Movaghar A, Rataemane S, Sangchooli A, Sibeko G, Vella A, Vista S, Zare-Bidoky M, Zhao M, Javed A, Potenza M, Baldacchino A. World addiction medicine reports: formation of the International Society of Addiction Medicine Global Expert Network (ISAM-GEN) and its global surveys. Frontiers In Psychiatry 2024, 15: 1230318. PMID: 38528974, PMCID: PMC10961370, DOI: 10.3389/fpsyt.2024.1230318.
- Melby K, Farokhnia M, Tolomeo S, Bhad R, Bramnes J, Baldacchino A, Rao R, Kandasami G, Butner J, Phan V, Fonseca F, Rafei P, Long J, Tzeferakos G, Dom G. International perspectives on opioid use disorder and treatment: Results from an online convenience sample. Heroin Addiction And Related Clinical Problems 2024, 26: 1-8. DOI: 10.62401/2531-4122-2024-5.
- Hill K, Dunham K, Brokos Z, Butner J, Hull I, Sue K, Li L, Thakarar K. In Support of Community Drug Checking Programs: Position Statement of AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction). Substance Use & Addiction Journal 2023, 45: 4-9. PMID: 38258861, DOI: 10.1177/29767342231212787.
- Tay Wee Teck J, Butner J, Baldacchino A. Understanding the use of telemedicine across different opioid use disorder treatment models: A scoping review. Journal Of Telemedicine And Telecare 2023, 1357633x231195607. PMID: 37661829, DOI: 10.1177/1357633x231195607.
- Bhad R, Achab S, Rafei P, Kathiresan P, Ardabili H, Butner J, Orsolini L, Melby K, Farokhnia M, Narasimha V, Ridley K, Tolomeo S, Kanabar M, Matanje B, Grandinetti P, Consortium I, Potenza M, Ekhtiari H, Baldacchino A. An online global survey and follow-up expert groups on the scope and needs related to training, research, and mentorship among early-career addiction medicine professionals. Cambridge Prisms Global Mental Health 2023, 10: e44. PMID: 37854423, PMCID: PMC10579666, DOI: 10.1017/gmh.2023.35.
- Christian N, Butner J, Evarts M, Weimer M. Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report. Journal Of Addiction Medicine 2023, 17: 488-490. PMID: 37579118, DOI: 10.1097/adm.0000000000001151.
- Haque LY, Butner JL, Shi JM, Henry S, Deng Y, Ciarleglio MM, Madden LM, Tetrault JM. Primary Care Associated With Follow Up Viral Load Testing in Patients Cured of Hepatitis C Infection With Direct Acting Antivirals at a Multidisciplinary Addiction Treatment Program: Insights From a Real-World Setting. Journal Of Addiction Medicine 2022, 16: 333-339. PMID: 34483278, PMCID: PMC9033626, DOI: 10.1097/adm.0000000000000910.
- Narasimha VL, Butner J, Hanafi E, Farokhnia M, Bhad R, Chalabianloo F, Kouimtsidis C, Baldacchino A, Arunogiri S. Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspective. BJPsych International 2022, 19: 66-69. PMID: 36287782, PMCID: PMC9540565, DOI: 10.1192/bji.2022.1.
- Flavin L, Tofighi B, Krawczyk N, Schatz D, McNeely J, Butner J. Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report. Journal Of Addiction Medicine 2022, 16: e59-e61. PMID: 35120069, PMCID: PMC8815634, DOI: 10.1097/ADM.0000000000000836.
- Ardabili H, Akbari A, Rafei P, Butner J, Khan R, Khazaal Y, Arab AZ, Qazizada MR, Al-Ansari B, Baldacchino AM. Tramadol, captagon and khat use in the Eastern Mediterranean Region: opening Pandora's box. BJPsych International 2021, 19: 58-62. PMID: 36287793, PMCID: PMC9540563, DOI: 10.1192/bji.2021.53.
- Radfar SR, De Jong CAJ, Farhoudian A, Ebrahimi M, Rafei P, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Massah O, Deylamizadeh A, Brady KT, Busse A, Consortium I, Potenza M, Ekhtiari H, Baldacchino A, Abagiu A, Abouna F, Ahmed M, Al-ansari B, Abu Al-khair F, Almaqbali M, Ambekar A, Ardabili H, Arya S, Lasebikan V, Ayasreh M, Basu D, Benmebarek Z, Bhad R, Blaise M, Bonnet N, Brasch J, Broers B, Butner J, Camilleri M, Campello G, Carra G, Celic I, Chalabianloo F, Chaturvedi A, de Jesús Eduardo Noyola Cherpitel J, Clark K, Cyders M, de Bernardis E, Derry J, Dhagudu N, Dolezalova P, Dom G, Dunlop A, Elhabiby M, Elkholy H, Essien N, Farah G, Ferri M, Floros G, Friedman C, Fuderanan C, Gerra G, Ghosh A, Gogia M, Grammatikopoulos I, Grandinetti P, Guirguis A, Gutnisky D, Haber P, Hassani-Abharian P, Hooshyari Z, Ibrahim I, Ieong H, Indradewi R, Iskandar S, Jain S, James S, Javadi S, Joe K, Jokubonis D, Jovanova A, Kamal R, Kantchelov A, Kathiresan P, Katzman G, Kawale P, Kern A, Kessler F, Kim S, Kimball A, Kljucevic Z, Siste K, Lev R, Lee H, Lengvenyte A, Lev-ran S, Mabelya G, Mahi M, Maphisa J, Maremmani I, Masferrer L, McCambridge O, McGovern G, Min A, Moghanibashi-Mansourieh A, Mora-Rios J, Mudalige I, Mukherjee D, Munira P, Myers B, N J, Narasimha V, Ndionuka N, Nejatisafa A, Niaz K, Nizami A, Nuijens J, Orsolini L, Oum V, Oyemade A, Palavra I, Pant S, Paredes J, Peyron E, Quirós R, Qurishi R, Rafiq N, Rao R, Ratta-apha W, Raymond K, Reimer J, Renaldo E, Rezapour T, Robertson J, Roncero C, Roub F, Rubenstein E, Rupp C, Saenz E, Salehi M, Samartzis L, Sarubbo L, Segrec N, Shah B, Shen H, Shirasaka T, Shoptaw S, Sintango F, Sosa V, Subata E, Sztycberg N, Taghizadeh F, Teck J, Tjagvad C, Torrens M, Twala J, Vadivel R, Volpicelli J, Weijs J, Wintoniw S, Wittayanookulluk A, Wojnar M, Yasir S, Yitayih Y, Zhao M, Zonoozi A. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey. Frontiers In Psychiatry 2021, 12: 639393. PMID: 34025471, PMCID: PMC8135096, DOI: 10.3389/fpsyt.2021.639393.
- Butner JL, Bone C, Martinez C, Kwon G, Beitel M, Madden LM, Bono MH, Eller A, Barry DT. Training Addiction Counselors to Deliver a Brief Psychoeducational Intervention for Chronic Pain among Patients in Opioid Agonist Treatment: A Pilot Investigation. Substance Abuse 2018, 39: 199-205. PMID: 29522379, DOI: 10.1080/08897077.2018.1449052.
- Butner JL, Gupta N, Fabian C, Henry S, Shi JM, Tetrault JM. Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program. Journal Of Substance Use And Addiction Treatment 2017, 75: 49-53. PMID: 28237054, DOI: 10.1016/j.jsat.2016.12.014.
- Tetrault JM, Butner JL. Non-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A Review. The Yale Journal Of Biology And Medicine 2015, 88: 227-33. PMID: 26339205, PMCID: PMC4553642.
Departments and Programs
Titles
- Assistant Professor Adjunct of Medicine (General Medicine), Assistant Clinical Professor (Yale School of Nursing)
Education & Training
- MPHYale School of Public Health, Public Health (2024)
- FellowYale University School of Medicine (2015)
- FellowMount Sinai Beth Israel (2014)
- ResidencyAlbert Einstein: Bronx Lebanon (2013)
- MDRoss University School of Medicine, Medicine (2009)
- ABState University of New York , Biology & Spanish (2005)
Languages Spoken
- English
- Español (Spanish)
Additional Information
Honors & Recognitions
- Annenberg Physician Training Program Fellowship Recipient: Ulrich & Ruth Frank Foundation for International Health (2022)
- Employee of the Year: APT Foundation (2015)
- Educational Finalist: American Society of Addiction Medicine: Connecticut Chapter (2015)
- Ruth Fox Scholarship Recipient: American Society of Addiction Medicine (2015)
Board Certifications
- AB of Preventive Medicine, Addiction Medicine (Internal Medicine) (2018)
Professional Service
- Violence Intervention Training, Advocacy and Education (VITAE), Yale School of Public Health (2023 - Present): Co-Founder
- Addiction Science & Clinical Practice (2021 - Present): Reviewer
- International Society of Addiction Medicine, Practice and Policy Interest Group (2020 - Present): Co-Chair
- American Academy of HIV Medicine (2020 - Present): Mentor
- ISAM-NExT (New Professionals Exploration,Training & Education), Mentorship Subcommittee (2020 - Present): Co-Chair
- Journal of Addiction Medicine (2020 - Present): Reviewer
- International Journal of Drug Policy (2020 - Present): Reviewer
- AZAHAR Foundation (2019 - Present): Board Member
- Providers Clinical Support System (PCSS) (2017 - Present): Mentor
- American Academy of HIV Medicine (2016 - Present): Member
Publications
- Dunham K, Hill K, Kazal H, Butner J, Hull I, Sue K, Li L, Doneski K, Dinges B, Rife-Pennington T, Kung S, Thakarar K. In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction). Substance Use & Addiction Journal 2024, 29767342241252590. PMID: 38747578, DOI: 10.1177/29767342241252590.
- Kanabar M, Kathiresan P, Elkholy H, Zonoozi A, Orsolini L, Long J, Farokhnia M, Bhad R, Butner J, Fonseca F, Phan V, Achab S, Potenza M. Spirituality and behavioural addictions: narrative review. BJPsych International 2024, 1-3. DOI: 10.1192/bji.2024.9.
- Allcroft H, Heiman E, Butner J. Clinical progress note: Xylazine use and its sequelae. Journal Of Hospital Medicine 2024 PMID: 38561251, DOI: 10.1002/jhm.13338.
- Ekhtiari H, Khojasteh Zonoozi A, Rafei P, Abolghasemi F, Pemstein D, Abdelgawad T, Achab S, Ghafri H, Al'Absi M, Bisch M, Conti A, Ambekar A, Arunogiri S, Bhad R, Bilici R, Brady K, Bunt G, Busse A, Butner J, Danesh A, El-Khoury J, Omari F, Jokūbonis D, de Jong C, Dom G, Ebrahimi M, Fathi Jouzdani A, Ferri M, Galea-Singer S, Parker D, Higuchi S, Kathiresan P, Khelifa E, Kouimtsidis C, Krupitsky E, Long J, Maremmani I, McGovern G, Mohaddes Ardabili H, Rahimi-Movaghar A, Rataemane S, Sangchooli A, Sibeko G, Vella A, Vista S, Zare-Bidoky M, Zhao M, Javed A, Potenza M, Baldacchino A. World addiction medicine reports: formation of the International Society of Addiction Medicine Global Expert Network (ISAM-GEN) and its global surveys. Frontiers In Psychiatry 2024, 15: 1230318. PMID: 38528974, PMCID: PMC10961370, DOI: 10.3389/fpsyt.2024.1230318.
- Melby K, Farokhnia M, Tolomeo S, Bhad R, Bramnes J, Baldacchino A, Rao R, Kandasami G, Butner J, Phan V, Fonseca F, Rafei P, Long J, Tzeferakos G, Dom G. International perspectives on opioid use disorder and treatment: Results from an online convenience sample. Heroin Addiction And Related Clinical Problems 2024, 26: 1-8. DOI: 10.62401/2531-4122-2024-5.
- Hill K, Dunham K, Brokos Z, Butner J, Hull I, Sue K, Li L, Thakarar K. In Support of Community Drug Checking Programs: Position Statement of AMERSA, Inc. (Association for Multidisciplinary Education and Research in Substance use and Addiction). Substance Use & Addiction Journal 2023, 45: 4-9. PMID: 38258861, DOI: 10.1177/29767342231212787.
- Tay Wee Teck J, Butner J, Baldacchino A. Understanding the use of telemedicine across different opioid use disorder treatment models: A scoping review. Journal Of Telemedicine And Telecare 2023, 1357633x231195607. PMID: 37661829, DOI: 10.1177/1357633x231195607.
- Bhad R, Achab S, Rafei P, Kathiresan P, Ardabili H, Butner J, Orsolini L, Melby K, Farokhnia M, Narasimha V, Ridley K, Tolomeo S, Kanabar M, Matanje B, Grandinetti P, Consortium I, Potenza M, Ekhtiari H, Baldacchino A. An online global survey and follow-up expert groups on the scope and needs related to training, research, and mentorship among early-career addiction medicine professionals. Cambridge Prisms Global Mental Health 2023, 10: e44. PMID: 37854423, PMCID: PMC10579666, DOI: 10.1017/gmh.2023.35.
- Christian N, Butner J, Evarts M, Weimer M. Precipitated Opioid Withdrawal Treated With Ketamine in a Hospitalized Patient: A Case Report. Journal Of Addiction Medicine 2023, 17: 488-490. PMID: 37579118, DOI: 10.1097/adm.0000000000001151.
- Haque LY, Butner JL, Shi JM, Henry S, Deng Y, Ciarleglio MM, Madden LM, Tetrault JM. Primary Care Associated With Follow Up Viral Load Testing in Patients Cured of Hepatitis C Infection With Direct Acting Antivirals at a Multidisciplinary Addiction Treatment Program: Insights From a Real-World Setting. Journal Of Addiction Medicine 2022, 16: 333-339. PMID: 34483278, PMCID: PMC9033626, DOI: 10.1097/adm.0000000000000910.
- Narasimha VL, Butner J, Hanafi E, Farokhnia M, Bhad R, Chalabianloo F, Kouimtsidis C, Baldacchino A, Arunogiri S. Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspective. BJPsych International 2022, 19: 66-69. PMID: 36287782, PMCID: PMC9540565, DOI: 10.1192/bji.2022.1.
- Flavin L, Tofighi B, Krawczyk N, Schatz D, McNeely J, Butner J. Low Threshold Telemedicine-based Opioid Treatment for Criminal Justice Involved Adults During the COVID-19 Pandemic: A Case Report. Journal Of Addiction Medicine 2022, 16: e59-e61. PMID: 35120069, PMCID: PMC8815634, DOI: 10.1097/ADM.0000000000000836.
- Ardabili H, Akbari A, Rafei P, Butner J, Khan R, Khazaal Y, Arab AZ, Qazizada MR, Al-Ansari B, Baldacchino AM. Tramadol, captagon and khat use in the Eastern Mediterranean Region: opening Pandora's box. BJPsych International 2021, 19: 58-62. PMID: 36287793, PMCID: PMC9540563, DOI: 10.1192/bji.2021.53.
- Radfar SR, De Jong CAJ, Farhoudian A, Ebrahimi M, Rafei P, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Massah O, Deylamizadeh A, Brady KT, Busse A, Consortium I, Potenza M, Ekhtiari H, Baldacchino A, Abagiu A, Abouna F, Ahmed M, Al-ansari B, Abu Al-khair F, Almaqbali M, Ambekar A, Ardabili H, Arya S, Lasebikan V, Ayasreh M, Basu D, Benmebarek Z, Bhad R, Blaise M, Bonnet N, Brasch J, Broers B, Butner J, Camilleri M, Campello G, Carra G, Celic I, Chalabianloo F, Chaturvedi A, de Jesús Eduardo Noyola Cherpitel J, Clark K, Cyders M, de Bernardis E, Derry J, Dhagudu N, Dolezalova P, Dom G, Dunlop A, Elhabiby M, Elkholy H, Essien N, Farah G, Ferri M, Floros G, Friedman C, Fuderanan C, Gerra G, Ghosh A, Gogia M, Grammatikopoulos I, Grandinetti P, Guirguis A, Gutnisky D, Haber P, Hassani-Abharian P, Hooshyari Z, Ibrahim I, Ieong H, Indradewi R, Iskandar S, Jain S, James S, Javadi S, Joe K, Jokubonis D, Jovanova A, Kamal R, Kantchelov A, Kathiresan P, Katzman G, Kawale P, Kern A, Kessler F, Kim S, Kimball A, Kljucevic Z, Siste K, Lev R, Lee H, Lengvenyte A, Lev-ran S, Mabelya G, Mahi M, Maphisa J, Maremmani I, Masferrer L, McCambridge O, McGovern G, Min A, Moghanibashi-Mansourieh A, Mora-Rios J, Mudalige I, Mukherjee D, Munira P, Myers B, N J, Narasimha V, Ndionuka N, Nejatisafa A, Niaz K, Nizami A, Nuijens J, Orsolini L, Oum V, Oyemade A, Palavra I, Pant S, Paredes J, Peyron E, Quirós R, Qurishi R, Rafiq N, Rao R, Ratta-apha W, Raymond K, Reimer J, Renaldo E, Rezapour T, Robertson J, Roncero C, Roub F, Rubenstein E, Rupp C, Saenz E, Salehi M, Samartzis L, Sarubbo L, Segrec N, Shah B, Shen H, Shirasaka T, Shoptaw S, Sintango F, Sosa V, Subata E, Sztycberg N, Taghizadeh F, Teck J, Tjagvad C, Torrens M, Twala J, Vadivel R, Volpicelli J, Weijs J, Wintoniw S, Wittayanookulluk A, Wojnar M, Yasir S, Yitayih Y, Zhao M, Zonoozi A. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey. Frontiers In Psychiatry 2021, 12: 639393. PMID: 34025471, PMCID: PMC8135096, DOI: 10.3389/fpsyt.2021.639393.
- Butner JL, Bone C, Martinez C, Kwon G, Beitel M, Madden LM, Bono MH, Eller A, Barry DT. Training Addiction Counselors to Deliver a Brief Psychoeducational Intervention for Chronic Pain among Patients in Opioid Agonist Treatment: A Pilot Investigation. Substance Abuse 2018, 39: 199-205. PMID: 29522379, DOI: 10.1080/08897077.2018.1449052.
- Butner JL, Gupta N, Fabian C, Henry S, Shi JM, Tetrault JM. Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program. Journal Of Substance Use And Addiction Treatment 2017, 75: 49-53. PMID: 28237054, DOI: 10.1016/j.jsat.2016.12.014.
- Tetrault JM, Butner JL. Non-Medical Prescription Opioid Use and Prescription Opioid Use Disorder: A Review. The Yale Journal Of Biology And Medicine 2015, 88: 227-33. PMID: 26339205, PMCID: PMC4553642.
Departments and Programs